| 48 |
Evaluation |
Pending Review |
09/01/2022 |
|
| 232 |
Sputum Smear Microscopy: Disposal Procedures |
Pending Review |
25/01/2022 |
|
| 233 |
Recommended Disinfectants for TB Laboratories |
Pending Review |
25/01/2022 |
|
| 253 |
Testing for TBI |
Pending Review |
26/01/2022 |
|
| 255 |
Follow-up for TPT |
Pending Review |
26/01/2022 |
|
| 256 |
Treatment outcome for TPT |
Pending Review |
26/01/2022 |
|
| 282 |
Precautions to be taken while collecting sputum |
Pending Review |
26/01/2022 |
|
| 348 |
Air exchanges per Hour |
Pending Review |
29/01/2022 |
|
| 396 |
CBNAAT Xpert Ultra Assay/Cartridge |
Pending Review |
09/02/2022 |
|
| 513 |
Drug-resistant Tuberculosis |
Pending Review |
06/03/2022 |
|
| 574 |
Linkages to Social Support Scheme |
Pending Review |
24/03/2022 |
|
| 842 |
Managerial Skills |
Pending Review |
27/03/2022 |
|
| 846 |
Reconstitution of drugs like second line, newer, TPT etc |
Pending Review |
27/03/2022 |
|
| 850 |
Stock register for Drugs |
Pending Review |
27/03/2022 |
|
| 869 |
Incentive For Notification and Outcome Declaration |
Pending Review |
27/03/2022 |
|
| 866 |
PHA for patient notified from the private sector |
Pending Review |
27/03/2022 |
|
| 980 |
Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Pre-existing Liver Disease |
Pending Review |
07/04/2022 |
|
| 989 |
Management of DR-TB ADR: Giddiness |
Pending Review |
07/04/2022 |
|
| 990 |
Management of DR-TB ADR: Hematological Abnormalities |
Pending Review |
07/04/2022 |
|
| 991 |
Management of DR-TB ADR: Hypothyroidism |
Pending Review |
07/04/2022 |
|
| 992 |
Management of DR-TB ADR: Arthralgia |
Pending Review |
07/04/2022 |
|
| 993 |
Management of DR-TB ADR: Depression |
Pending Review |
07/04/2022 |
|
| 994 |
Management of DR-TB ADR: Psychotic Symptoms |
Pending Review |
07/04/2022 |
|
| 995 |
Management of DR-TB ADR: Suicidal Ideation |
Pending Review |
07/04/2022 |
|
| 996 |
Management of DR-TB ADR: Seizures |
Pending Review |
07/04/2022 |
|
| 997 |
Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity] |
Pending Review |
07/04/2022 |
|
| 998 |
Management of DR-TB ADR: Gynecomastia |
Pending Review |
07/04/2022 |
|
| 1061 |
Newer Anti-TB Drugs: Delamanid [Dlm] |
Pending Review |
07/04/2022 |
|
| 1063 |
Pre-treatment Counselling of DR-TB Patients |
Pending Review |
07/04/2022 |
|
| 1069 |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE] |
Pending Review |
07/04/2022 |
|
